hypertensive%20crisis
HYPERTENSIVE CRISIS
Hypertensive emergency is having severely elevated blood pressure (>180-220 mmHg/120-130 mmHg) that is complicated by progressive target end-organ damage of the central nervous system, heart, kidneys, or the gravid uterus.
There is no definite blood pressure threshold for the diagnosis of hypertensive emergency.
Most target end-organ damage happen with diastolic blood pressure of ≥130 mmHg.
Hypertensive urgency refers to patients with severely elevated blood pressure (>180/110-120 mmHg) but with little or no evidence of acute end-organ damage.
The clinical differentiation between hypertensive emergencies and urgencies is dependent on the presence of target end-organ damage rather than the level of blood pressure.
Drug Information

Indication: HTN.

Indication: HTN. Adjunct to digitalis &/or diuretic therapy in CHF.

Indication: CHD: Chronic stable angina pectoris; HTN.

Indication: HTN; angina pectoris; MI. Disturbances of cardiac rhythm including supraventricular tachycardia. Functional he...

Indication: Control of BP in peri-op HTN. CHF associated w/ acute MI. Angina pectoris unresponsive to recommended doses of...

Dosage: Essential HTN Initially 10-20 mg daily. Maintenance: 20 mg once daily. Max: 40 mg daily. Renovascular HTN Init

Indication: Angina pectoris, CHF.

Indication: Treatment & prophylaxis of angina pectoris & treatment of variant angina.

Indication: Severe HTN in pregnancy. Hypotensive anaesth. Hypertensive episodes following acute MI.

Dosage: HTN 100-400 mg as single or bd dose. Angina pectoris 50-100 mg bd-tds. Cardiac arrhythmias 50 mg bd-tds up to

1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 23 May 2019
A recent study has shown an association between regular use of glucosamine supplement to relieve osteoarthritis pain and lower risk of cardiovascular disease (CVD) events.
Stephen Padilla, 11 Feb 2020
The inclusion of two proanthocyanidin (PA)-rich apples into normal diets improves cardiovascular disease (CVD) risk factors by reducing total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and intercellular cell adhesion molecule-1 (ICAM-1), as well as increasing microvascular vasodilation, in individuals with mildly elevated serum cholesterol concentrations, a recent study has shown.
Roshini Claire Anthony, 21 Dec 2019

In acutely ill medical patients, asymptomatic proximal deep-vein thrombosis (ASxDVT), as assessed via compression ultrasonography, is associated with an elevated risk of all-cause mortality, according to a post hoc analysis of the MAGELLAN* trial presented at ASH 2019.

Tristan Manalac, 14 Dec 2019
Luspatercept promotes red blood cell (RBC) transfusion independence among low-risk myelodysplastic syndrome (MDS) patients, according to a longer-term analysis of the MEDALIST study presented at the recently concluded 61st Annual Meeting and Exposition of the American Society of Hematology (ASH 2019).